Boone Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-101,508
Closed -$29.2M 22
2023
Q4
$29.2M Buy
101,508
+3,382
+3% +$921K 6.82% 3
2023
Q3
$26.4M Buy
98,126
+14,627
+18% +$3.65M 8.32% 6
2023
Q2
$18.5M Buy
83,499
+4,349
+5% +$1.01M 6.65% 7
2023
Q1
$19.1M Buy
+79,150
New +$19.4M 8.96% 5

Other funds holding AMGN

Boone Capital Management's AMGN Position: Q1 2024 in Review

Boone Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 101,508 shares — an estimated $29.2M sold.

Boone Capital Management first reported a position in AMGN in Q1 2023 and held it in 4 quarters. The position peaked at $29.2M in Q4 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Boone Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Boone Capital Management sold 101,508 Amgen shares in Q1 2024, an estimated $29.2M.
  • Boone Capital Management first reported a position in Amgen in Q1 2023 and held it in 4 quarters.
  • Boone Capital Management's Amgen position peaked at $29.2M in Q4 2023.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Boone Capital Management's 13F filing for Q1 2024, filed 15 May 2024.